Literature DB >> 6838485

Amino acid sequence of the active site of human pseudocholinesterase.

K Yamato, I Y Huang, H Muensch, A Yoshida, H W Goedde, D P Agarwal.   

Abstract

The usual E1u and atypical E1a human pseudocholinesterases (acylcholine acylhydrolase, EC 3.1.1.8) were purified to homogeneity. The active-site serine residue was conjugated with diisopropyl fluorophosphate and digested with trypsin. The tryptic peptide containing the active site was isolated by gel filtration followed by two-dimensional paper chromatography and electrophoresis. The amino acid sequence of the active site peptide obtained from the usual E1u enzyme was found to be Gly-Glu-Ser-Ala-Gly-Ala-Ser-Ala-Val-Ser-Leu. A remarkable structural homology exists between the human and the horse enzymes in their active sites. From the difference in electrophoretic mobility of the active-site peptides obtained from the usual and atypical enzymes, the probable structure of the atypical human enzyme was deduced as Gly-His-Ser-Ala-Gly-Ala-Ser-Ala-Val-Ser-Leu.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6838485     DOI: 10.1007/bf02395397

Source DB:  PubMed          Journal:  Biochem Genet        ISSN: 0006-2928            Impact factor:   1.890


  25 in total

1.  On the active site of horse-liver ali esterase. II. Amino acid sequence in the DFP-binding site of the enzyme.

Authors:  H S JANSZ; C H POSTHUMUS; J A COHEN
Journal:  Biochim Biophys Acta       Date:  1959-06

2.  COMPLETE PSEUDOCHOLINESTERASE DEFICIENCY: GENETIC AND IMMUNOLOGIC CHARACTERIZATION.

Authors:  W HODGKIN; E R GIBLETT; H LEVINE; W BAUER; A G MOTULSKY
Journal:  J Clin Invest       Date:  1965-03       Impact factor: 14.808

3.  The action of normal and atypical cholinesterase of human serum upon a series of esters of choline.

Authors:  R O DAVIES; A V MARTON; W KALOW
Journal:  Can J Biochem Physiol       Date:  1960-06

4.  Some statistical data on atypical cholinesterase of human serum.

Authors:  W KALOW; D R GUNN
Journal:  Ann Hum Genet       Date:  1959-07       Impact factor: 1.670

5.  On distribution and inheritance of atypical forms of human serum cholinesterase, as indicated by dibucaine numbers.

Authors:  W KALOW; N STARON
Journal:  Can J Biochem Physiol       Date:  1957-12

6.  Amino acid sequence in the region of the reactive serine residue of eel acetylcholinesterase.

Authors:  N K Schaffer; H O Michel; A F Bridges
Journal:  Biochemistry       Date:  1973-07-17       Impact factor: 3.162

7.  Thin-layer chromatography of sub-nanomole amounts of phenylthiohydantoin (PTH) amino acids on polyamide sheets.

Authors:  M R Summers; G W Smythers; S Oroszlan
Journal:  Anal Biochem       Date:  1973-06       Impact factor: 3.365

8.  Protein purification by affinity chromatography. Derivatizations of agarose and polyacrylamide beads.

Authors:  P Cuatrecasas
Journal:  J Biol Chem       Date:  1970-06       Impact factor: 5.157

9.  A study of the pseudocholinesterase in 78 cases of apnoea following suxamethonium.

Authors:  J C Thompson; M Whittaker
Journal:  Acta Genet Stat Med       Date:  1966

10.  Structural difference at the active site of dibucaine resistant variant of human plasma cholinesterase.

Authors:  H Muensch; A Yoshida; K Altland; W Jensen; H W Goedde
Journal:  Am J Hum Genet       Date:  1978-05       Impact factor: 11.025

View more
  3 in total

1.  Identification of the structural mutation responsible for the dibucaine-resistant (atypical) variant form of human serum cholinesterase.

Authors:  M C McGuire; C P Nogueira; C F Bartels; H Lightstone; A Hajra; A F Van der Spek; O Lockridge; B N La Du
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

Review 2.  Pharmacogenetics and ecogenetics.

Authors:  D P Agarwal; H W Goedde
Journal:  Experientia       Date:  1986-10-15

3.  Amino acid sequence of the active site of human serum cholinesterase from usual, atypical, and atypical-silent genotypes.

Authors:  O Lockridge; B N La Du
Journal:  Biochem Genet       Date:  1986-06       Impact factor: 1.890

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.